These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8877675)

  • 1. Population pharmacokinetics of intravenous amiodarone in patients with refractory ventricular tachycardia/fibrillation.
    Korth-Bradley JM; Rose GM; de Vane PJ; Peters J; Chiang ST
    J Clin Pharmacol; 1996 Aug; 36(8):715-9. PubMed ID: 8877675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of intravenous amiodarone in patients with impaired left ventricular function.
    Vadiei K; O'Rangers EA; Klamerus KJ; Kluger J; Kazierad DJ; Leese PT; Chow MS; Zimmerman JJ
    J Clin Pharmacol; 1996 Aug; 36(8):720-7. PubMed ID: 8877676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetic investigation for optimization of amiodarone therapy in Japanese patients.
    Araki R; Yukawa E; Nakashima MN; Fukuchi H; Sasaki H; Yano K; Nakashima M
    Ther Drug Monit; 2011 Dec; 33(6):750-6. PubMed ID: 22105593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous amiodarone.
    Med Lett Drugs Ther; 1995 Dec; 37(963):114-5. PubMed ID: 7500909
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous amiodarone: pharmacology, pharmacokinetics, and clinical use.
    Chow MS
    Ann Pharmacother; 1996 Jun; 30(6):637-43. PubMed ID: 8792951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of intravenous amiodarone and comparison with two-stage pharmacokinetic analysis.
    Vadiei K; Troy S; Korth-Bradley J; Chiang ST; Zimmerman JJ
    J Clin Pharmacol; 1997 Jul; 37(7):610-7. PubMed ID: 9243354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative bioavailability of a premixed, ready-to-use formulation of intravenous amiodarone with traditional admixture in healthy subjects.
    Cushing DJ; Adams MP; Cooper WD; Agha B; Souney PF
    J Clin Pharmacol; 2012 Feb; 52(2):214-21. PubMed ID: 21257800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group.
    Kowey PR; Levine JH; Herre JM; Pacifico A; Lindsay BD; Plumb VJ; Janosik DL; Kopelman HA; Scheinman MM
    Circulation; 1995 Dec; 92(11):3255-63. PubMed ID: 7586312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: minimum of three-year follow-up in 145 patients.
    Myers M; Peter T; Weiss D; Nalos PC; Gang ES; Oseran DS; Mandel WJ
    Am Heart J; 1990 Jan; 119(1):8-14. PubMed ID: 2296879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of vernakalant hydrochloride injection (RSD1235) in patients with atrial fibrillation or atrial flutter.
    Mao ZL; Townsend RW; Gao Y; Wheeler JJ; Kastrissios H; Keirns J
    J Clin Pharmacol; 2012 Jul; 52(7):1042-53. PubMed ID: 21659624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence of 2 intravenous amiodarone formulations in healthy participants.
    Cushing DJ; Adams MP; Cooper WD; Kowey PR; Lipicky RJ
    J Clin Pharmacol; 2009 Apr; 49(4):407-15. PubMed ID: 19246726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation.
    Schützenberger W; Leisch F; Kerschner K; Harringer W; Herbinger W
    Br Heart J; 1989 Nov; 62(5):367-71. PubMed ID: 2590589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renewed impact of lidocaine on refractory ventricular arrhythmias in the amiodarone era.
    Yoshie K; Tomita T; Takeuchi T; Okada A; Miura T; Motoki H; Ikeda U
    Int J Cardiol; 2014 Oct; 176(3):936-40. PubMed ID: 25201023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amiodarone absorption and elimination after oral and intravenous administration in healthy individuals].
    Gaete LE; Ortiz M; Soto J; Saavedra I
    Rev Med Chil; 1995 Jun; 123(6):713-9. PubMed ID: 8525224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of long-term oral amiodarone therapy.
    Pollak PT; Bouillon T; Shafer SL
    Clin Pharmacol Ther; 2000 Jun; 67(6):642-52. PubMed ID: 10872646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous antiarrhythmic therapy in the acute control of in-hospital destabilizing ventricular tachycardia and fibrillation.
    Kowey PR; Marinchak RA; Rials SJ; Bharucha DB
    Am J Cardiol; 1999 Nov; 84(9A):46R-51R. PubMed ID: 10568659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of intravenous agents for ventricular arrhythmias.
    Nolan PE
    Pharmacotherapy; 1997; 17(2 Pt 2):65S-75S; discussion 89S-91S. PubMed ID: 9085342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone or nifekalant upon hospital arrival for refractory ventricular fibrillation after out-of-hospital cardiac arrest.
    Tagami T; Matsui H; Ishinokami S; Oyanagi M; Kitahashi A; Fukuda R; Unemoto K; Fushimi K; Yasunaga H
    Resuscitation; 2016 Dec; 109():127-132. PubMed ID: 27568110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based analysis of amiodarone efficacy and safety.
    Connolly SJ
    Circulation; 1999 Nov; 100(19):2025-34. PubMed ID: 10556230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.